Researchers are investigating who is at greatest risk for radiation-induced cancers.

by Kate Yandell

For people with melanoma who receive immune checkpoint inhibitors after surgery, side effects can remain even after treatment has been completed. These chronic side effects are most often mild.

by Anna Goshua

Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.

by Marci A. Landsmann

The immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors.

by Kate Yandell

From the Editor-in-Chief

Patients in this age group have particular needs, and cancer centers are beginning to tailor programs for them.

by William G. Nelson, MD, PhD

Sound Advice

vol 11 | issue 01
Maintaining relationships through cancer, feeling unappreciated as a caregiver, and finding information that's relevant to young people with cancer.

New drugs and drug combinations are helping more patients live longer with advanced kidney cancer. But questions remain about how best to choose among them.

by Kendall K. Morgan

Forward Look

Several targeted drugs were approved in 2020 to treat the most common type of lung cancer.

by Ashley P. Taylor

Survivor Profile

With a renewed sense of purpose, stage IV lung cancer survivor Oswald Peterson returns to his parents' native Trinidad to celebrate the Caribbean festival.

by Lindsey Konkel

Forward Look

A new way to evaluate patients with prostate cancer.

by Christina Bennett